Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;34(3 Suppl):1619-1628.
doi: 10.21873/invivo.11952.

Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature

Konstantinos A A Douglas #  1   2 , Vivian Paraskevi Douglas #  1 , Marilita M Moschos  3
Affiliations
Review

Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature

Konstantinos A A Douglas et al. In Vivo. 2020 Jun.

Abstract

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China in the city of Wuhan in December of 2019 and since then more than 5,000,000 people have been infected, with approximately 338,000 deaths worldwide. The virus causes the coronavirus disease 2019 (COVID-19), which is characterized by fever, myalgia and cough, with severe acute respiratory syndrome being the most fearsome complication. Nevertheless, the vast majority of cases present mild symptoms or none. Central nervous system and cardiovascular manifestations have been reported. The range of ocular manifestations, either as a result of the infection or as a result of the treatment, has not yet been discussed. In this study, a systematic review of current literature relevant to COVID-19 was performed with focus on modes of transmission, ocular manifestations related to infection and medications, as well as the control of infection in ophthalmic practice.

Keywords: COVID-19; ocular manifestations; ophthalmology; prevention; review; side-effects; treatment.

PubMed Disclaimer

Conflict of interest statement

The Authors state that they have no conflicts of interest to declare.

References

    1. Coronavirus covid-19 (2019-ncov). Available at: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594....
    1. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, Megawati D, Hayati Z, Wagner AL, Mudatsir M. Coronavirus disease 2019 (covid-19): A literature review. J Infect Public Heal. 2020;13(5):667–673. doi: 10.1016/j.jiph.2020.03.019. - DOI - PMC - PubMed
    1. Wang H, Li X, Li T, Zhang S, Wang L, Wu X, Liu J. The genetic sequence, origin, and diagnosis of sars-cov-2. Eur J Clin Microbiol Infect Dis. 2020 doi: 10.1007/s10096-020-03899-4. - DOI - PMC - PubMed
    1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi: 10.1038/s41586-020-2012-7. - DOI - PMC - PubMed
    1. Ludvigsson JF. Systematic review of covid-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–1095. doi: 10.1111/apa.15270. - DOI - PMC - PubMed

MeSH terms